Abstract
A review of the impact of human papillomavirus (HPV)-positive squamous cell carcinoma of the head and neck on patients and their carers. Patients with HPV-mediated malignancy of the oropharynx present with distinct risk factors and a favourable prognosis compared to patients with HPV-negative disease. Despite the distinct clinical profile of HPV-positive malignancy, clinical recommendations do not account for HPV status. Consequently, patients with HPV-positive disease are receiving highly aggressive and often life-changing anti-cancer treatment despite a favourable prognosis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
